Drug regulator flagged 159 samples substandard in May, 1 found spurious
India's drug regulator, the CDSCO, identified 159 substandard drug samples and one spurious sample during routine surveillance in May. The findings are limited to specific batches and do not reflect the quality of all products from the manufacturers involved.
Why it matters
Ensuring pharmaceutical quality is critical for public health safety, and regulatory alerts help prevent the distribution of ineffective or dangerous medications.
Drug regulator flagged 159 samples substandard in May, 1 found spurious | India News - The Times of India
The article reports factual data from a government regulatory body without editorializing or taking a political stance.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in